INS and metabolic dysfunction-associated steatotic liver disease: The pathophysiological mechanisms behind the association of liver fibrosis in NAFLD with cardiovascular disease are still incompletely understood and may involve other pathways besides insulin resistance, such as oxidative stress, inflammation, and gut microbiota [32].